Quadria Capital Closes Oversubscribed US$1 Billion Fund III to Advance Healthcare Transformation Across Asia
Fund close exceeds initial target despite a challenging fundraising environment, reflecting strong investor confidence in India and Southeast Asia healthcare
Existing investors increased commitment amount by an average of 80%
New capital raised from blue-chip global institutions, alongside a significant rise in Asian investor participation
HO CHI MINH CITY, Vietnam, May 27, 2025--(BUSINESS WIRE)--Quadria Capital, Asia's premier healthcare-focused private equity firm, today announced the final close of its Fund III with US$1.07 billion in total commitments, significantly exceeding its original $800 million target.
The oversubscribed fundraise comprises over US$954 million in primary commitments and US$114 million in committed co-investment capital. An additional US$300 million co-investment capacity is anticipated over the course of the investment phase, bringing total committed capital to approximately US$1.3 billion upon full deployment.
This latest fundraise is around 60% larger than the firm's previous $600m fund raised in 2020, cementing Quadria's position as the largest dedicated healthcare private equity fund in South and Southeast Asia.
"Fund III's close, amid one of the most demanding fundraising climates in recent memory, is a powerful validation of our strategy and our mission," said Abrar Mir, Co-Founder and Managing Partner, Quadria Capital. "It reflects deep global investor conviction in the transformational opportunity in Asian Healthcare, where social impact and financial performance go hand in hand."
Global Institutional Backing Across Continents
At a time when global capital is cautious, Quadria's ability to consistently attract top-tier global investors underscores the strong conviction in its investment strategy and the undeniable opportunities in the Asian healthcare market.
Quadria Capital's largest existing backers include prominent North American and European sovereign wealth funds, asset managers, and strategic corporates. The Fund also secured new commitments from globally recognized institutional investors. Most notably, there was strong backing from leading institutions across the GCC, including Saudi Arabia, the UAE, and Bahrain. The fundraise further attracted interest from India, with fresh capital from major banks, insurance companies, and family offices. Additionally, the Fund received robust re-up commitments from impact investors - underscoring Quadria's continued dedication to scalable, high-impact healthcare businesses that deliver lifesaving care to underserved populations across Asia.
Positioned for Structural Growth in Vietnam's $25 Billion Healthcare Market
"Vietnam is at a crucial juncture in healthcare, driven by rapid urbanisation, rising incomes, and increased demand for superior medical services," said Ewan Davis, Partner at Quadria Capital. "Our approach combines deep local insights with globally proven best practices and significant capital resources to empower leading players in Vietnam's Healthcare segment."
Quadria's commitment to Vietnam is evident through its established local office in Ho Chi Minh City, led by an experienced team of Vietnamese professionals. Quadria offers a distinctive approach that combines financial backing with structured, hands-on support for long-term strategic growth. Its investments in FV Hospital - one of the nation's leading healthcare providers - resulted in major clinical improvements and substantial enhancements in patient outcomes. Likewise, Quadria's support helped consolidate Con Cung's position as a leading mother-and-baby retailer as a market leader, leveraging strategic improvements in governance, operational efficiency, and scalability.
"We believe Vietnam is entering a golden era of healthcare transformation," said Janice Trinh, Country Head for Vietnam. "With rising patient expectations, a new wave of medical talent, and increasing openness to innovation, the foundations are in place for a modern, inclusive, and world-class healthcare system. Quadria is deeply committed to supporting this momentum—by partnering with national healthcare leaders, we are actively empowering a robust medical ecosystem that delivers better, more affordable care to all Vietnamese."
About Quadria:
Founded in 2012, Quadria Capital is Asia's premier healthcare investor managing over US$4 billion in assets across 27 investments in South and Southeast Asia including India, Vietnam, Indonesia, Malaysia and Singapore. Quadria Capital aims to create significant and sustainable shareholder value by partnering with exceptional healthcare businesses to enhance their impact and scale, while generating superior returns for investors.
For more information, please visit www.quadriacapital.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250526982394/en/
Contacts
Media Contact: Yvette LimYvette.lim@fgsglobal.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNN
30 minutes ago
- CNN
Japan-based company is poised for its moon-landing attempt
Update: Date: Title: Ispace's CEO is "very confident" success is on the way Content: Takeshi Hakamada, who founded Ispace in 2010 and serves as the company's CEO, told CNN last month that he is far more optimistic about today's landing attempt than he was going into Ispace's first landing attempt in 2023. 'I'm very confident, more confident than (during) Mission 1,' Hakamada told CNN in May. Hakamada added that he's not a very emotional person, so cold feet and sleepless nights aren't necessarily part of his pre-landing routine. 'I'm not the person emotion so much. I don't feel any peace or joy sometimes — most of the times,' Hakamada, who says he was inspired to puruse an aerospace career by the 'Star Wars' movies, told CNN. 'The importance of this space business is keep going.' Update: Date: Title: Reslience is carrying science — and art Content: Tucked alongside a molecule-splitting science experiment and radiation monitor, Resilience is carrying a couple lighthearted pieces of commemorative art. One includes commemorative coin-sized plates designed by UNESCO and US-based Barrelhand that will 'transport and safeguard 275 distinct languages and cultural treasures on the lunar surface.' Another is from Swedish artist Mikael Genberg, who contributed a miniature red house dubbed the 'Moonhouse.' Genberg has been aiming to put a red house on the lunar surface for more than two decades. 'They wanted to send something to the moon, so there was a good coincidence,' Ispace chief financial officer Jumpei Nozaki told CNN in January, noting that Ispace's European branch in Luxembourg found out about the art piece and worked to put it on the Resilience lander. The pieces may join a slew of other novelties, art pieces and curiosities that have been part of past lunar missions. A Jeff Koons sculpture series called 'Moon Phases,' for example, flew on the Odysseus lunar lander from Houston-based Intuitive Machines last year, becoming the first 'authorized' work of art on the moon. The Moonhouse on board Resilience aims to be an 'expression of humanity's ability to achieve the seemingly unattainable through boundary-crossing thoughts and collaborations and maybe a symbol of humanity's eternal and collective striving; a perspective on existence and (an) eye towards Earth,' according to a web page about the art project. Update: Date: Title: Here's how (another) failed landing attempt could affect Ispace Content: Ispace's roots began in the Google Lunar XPrize, which in the 2010s challenged the private-sector to put robotic landers on the moon for a $20 million grand prize. The compeititon ended in 2018, however, with no winner. 'That was very good program for me to start things here,' Ispace CEO and founder Takeshi Hakamada told CNN in May. 'We survived the Lunar XPrize and and then that created credibility for the next fundraising (effort).' After the competition folded, Ispace kept going, bringing on new investors. And just before its first lunar landing attempt in 2023, the company went public, listing on Tokyo's stock exchange. When Ispace's first landing attempt failed in 2023, crashing to the moon due to a software issue, the company's stock price shed more than half its value. And Ispace could face some significant financial struggles if today's landing attempt is unsuccessful, Ispace chief financial officer Jumpei Nozaki told CNN in January. 'If we do not successfully land on the moon, maybe there are going to be some very strong headwinds against us. It will be reflected to our share price immediately,' Nozaki said. Still, Nozaki added, the company raised money last year around the world, including from one US investor, that should keep the company funded through a third lunar landing attempt. Update: Date: Title: Resilience is aiming to land farther north than other recent missions Content: We're in the midst of renewed space race, with both the public and private sector eager to send robots to further explore the lunar surface. The modern moon dash was largely kicked off by China, which safely landed its first Chang'e spacecraft in 2013 — roughly 40 years after any vehicle, crewed or uncrewed, had soft-landed on the lunar surface. Much of the lunar exploration focus has been on the south pole, as the region is expected to be home to vast stores of water ice that can be converted to drinking water or fuel for rockets. But the vehicles that have made soft landings so far have explored a variety of regions. Update: Date: Title: Soft landing on the moon is still really hard. Here's why Content: All lunar landing attempts — even missions such as this with no humans on board — bring with them an element of risk and awe. Success is far from guaranteed. Overall, more than half of all lunar landing attempts have ended in failure, tough odds for a feat humanity first pulled off nearly 60 years ago. While technology has advanced in the past five decades, the fundamental challenges of landing on the moon remain the same. Here's what Resilience has had to overcome — and what it has yet to face. Update: Date: Title: What went wrong during Ispace's last lunar landing attempt Content: Ispace's first lunar lander, referred to by its model name, Hakuto-R, made a dramatic crash landing on the moon in 2023. When the estimated landing time came and went, and mission controllers had spent about 10 minutes troubleshooting why the lander hadn't sent a signal, it was safe to assume the golf-cart-size vehicle had not made a gentle touchdown, Ispace CEO Takeshi Hakamada, told CNN. A NASA satellite later photographed the crash site. Ispace then spent weeks poring over the data, trying to pinpoint what went wrong. 'Almost everything performed perfectly — propulsion system, communication system, and also structure,' Ispace chief financial officer Jumpei Nozaki told CNN in January about the first Hakuto-R mission. 'The issue was the software and the altitude measurement has some issue.' Essentially, Hakuto-R had miscalculated its altitude, and the vehicle ended up running out of fuel before touching down on the surface. This time around, executives are far more confident. A software patch is in place. And mission controllers are hoping to get confirmation of a smooth touchdown within a minute or so after the 3:17 p.m. ET expected landing time. Update: Date: Title: Here's what to expect during today's moon-landing attempt Content: Resilience, a spacecraft built by Tokyo-based Ispace that could redeem the company after a failed moon-landing attempt in 2023, is ready to make its final descent to the lunar surface. Ispace has broken down its mission in to series of 10 goals or anticipated 'successes.' Resilience has already notched through the first eight of those steps. All that's left is the landing sequence and the harrowing moment of touchdown. Here are the key moments to watch out for: • During the touchdown attempt, Ispace will confirm it has started the 'lunar landing sequence' — the final steps the Resilience lander will need to tick through in the moments before the vehicle leaves it circular orbit around the moon and begins its touchdown attempt. • There a several critical phases within the sequence. The vehicle will begin to change its orientation and start the braking process, aiming to slow down Resilience's speed. • Resilience's targeted touchdown time is 3:17 p.m. ET. The lander is aiming for a spot within Mare Frigoris — or the 'Sea of Cold' — which lies in the moon's far northern reaches. • If all goes according to plan, Ispace should confirm the vehicle is safely on the surface within a minute or so after touchdown, the company's CEO, Takeshi Hakamada, told CNN. • Ground controllers will then conduct a series of health checks to make sure the lander, its science instruments and all other components are functioning as intended. • The first image from the lander is expected within the first 12 hours after the spacecraft reaches the surface, perhaps sooner. (Take note: Every lunar landing mission has to deal with limited bandwidth to beam data back to Earth. Sometimes, visuals are not the highest priority.)
Fox News
37 minutes ago
- Fox News
'Coming for us': Expert sounds alarm on CCP's mission to 'kill Americans' after FBI makes shocking arrests
VIDEO ID: 6373876764112 Following news that two Chinese nationals were charged with allegedly smuggling a "dangerous biological pathogen" into the United States to study at a U.S. university, Fox News Digital spoke to an expert on China who said the arrests should be a wake-up call to the country. "I was entirely unsurprised, which is a sad commentary, but it speaks to the Chinese Communist Party, the CCP wants to kill Americans," Michael Sobolik, a senior fellow at the Hudson Institute focusing on U.S. and China relations, told Fox News Digital after FBI Director Kash Patel announced the arrests of the two Chinese nationals. "Look at what they've done with smuggling fentanyl precursors into our country to kill Americans, look at the effects of them failing to stop the spread of COVID-19," Sobolik said. "Dead Americans. The fact that they want to target Americans here within the United States with pathogens and with bioweapons. This is the Chinese Communist Party. This is what they do. They're in a cold war with the United States. They want to become the most powerful nation in the world and they wanna make the world safe for their tyranny and unsafe for freedom. And they're coming for us here at home." The couple are accused of smuggling a fungus called Fusarium graminearum, which scientific literature classifies as a "potential agroterrorism weapon," according to the Justice Department. Federal prosecutors note that the noxious fungus causes "head blight," a disease of wheat, barley, maize, and rice, and "is responsible for billions of dollars in economic losses worldwide each year." The Justice Department also says fusarium graminearum's toxins cause vomiting, liver damage, and "reproductive defects in humans and livestock." According to the criminal complaint, one of the accused allegedly received Chinese government funding for her work on the pathogen in China. The couple are accused of bringing the pathogen into the U.S. to study at a University of Michigan laboratory, which raises more concerns about Chinese nationals infiltrating American universities. Last month, a bombshell report out of Stanford University shed light on the influence of spies from the Chinese Communist Party that the student newspaper says have likely infiltrated the prestigious institution and other universities nationwide to gather intelligence. "American higher education is addicted to the Chinese Communist Party," Sobolik told Fox News Digital. "It's addicted to easy money that has come from Beijing for decades. It's addicted to international students that pay full tuition, many of which are then coerced and pressured by the Chinese embassy and consulates and other networks to spy for the party and report back." "American universities need to finally open their eyes and stop being willfully blind to the threat of the CCP. They're vectors for intelligence gathering. They are vectors for these threats that target Americans on our own soil. That's unacceptable. If sovereignty means anything, we need to be able to protect Americans within the borders of the United States. And universities cannot continue to be willing accomplices of the Chinese Communist Party." A Chinese embassy official said Wednesday he was unaware of the case involving two Chinese nationals charged with smuggling a "dangerous biological pathogen" into the U.S. for university research. "I don't know the specific situation, but I would like to emphasize that the Chinese government has always required overseas Chinese citizens to abide by local laws and regulations and will also resolutely safeguard their legitimate rights and interests," said Liu Pengyu, spokesperson for the Chinese Communist Party (CCP) Embassy in the U.S.
Travel Weekly
43 minutes ago
- Travel Weekly
Anderson family sells stake in Avoya Travel to Certares
The Anderson family has sold its stake in Avoya Travel to Certares, the private equity firm that invested in the host agency in 2021. Certares has acquired full ownership of the company. Co-CEOs Jeff Anderson and Michael Anderson will remain with Avoya through mid-June to assist in the transition. Other members of Avoya's executive leadership team -- including chief sales officer Phil Cappelli and CFO Mark Francone -- remain with the host agency. "We're grateful to Jeff Anderson and Michael Anderson, who helped build Avoya into an innovative leader in leisure travel," Avoya said in a statement. The Anderson family had operated Avoya for decades. The late Pal Anderson, Avoya's founder, and his wife, Pat, entered the travel industry with a tour operation in Hawaii in 1964. They would go on to start a retail travel agency that eventually became Avoya. Its hosting operation began alongside the rise of the internet in the early 2000s. Pat and Pal's sons, Brad and Van, ran the company for years before handing over the reins to Jeff and Michael.
